BSX logo

Boston Scientific (BSX) Company Overview

Profile

Full Name:

Boston Scientific Corporation

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

May 19, 1992

Indexes:

S&P 500

Website:

http://www.bostonscientific.com

Description:

Boston Scientific Corporation is the world's largest developer and manufacturer of medical devices used in a wide range of medical specialties. The range of products produced is represented by 7 groups: Interventional Cardiology, Cardiac Rhythm, Endoscopy, Urology and Pelvic Organs, Peripheral Interventions, Neuromodulation, Electrophysiology. The company was founded in 1979 and its headquarters are located in Marlborough, Massachusetts.

Key Details

Price

$97.34

Market Cap

$143.65 B(Mega cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$16.75 B(+17.61% YoY)

Annual EPS

$1.25(+16.82% YoY)

PE Ratio

77.87

Annual ROE

8.93%

Annual Debt To Equity

0.49

Beta

0.61

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Feb 5, 2025

Recent annual earnings:

Feb 5, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 6, 2003

Analyst ratings

Recent major analysts updates

Mar 3, 25 Needham
Hold
Feb 10, 25 Stifel
Buy
Feb 10, 25 Barclays
Overweight
Feb 7, 25 UBS
Buy
Feb 6, 25 Wells Fargo
Overweight
Feb 6, 25 Stifel
Buy
Feb 6, 25 Raymond James
Strong Buy
Feb 6, 25 RBC Capital
Outperform
Feb 6, 25 Needham
Hold
Feb 6, 25 Morgan Stanley
Overweight

Screeners with BSX included

Growing Shares Outstanding
US stocks
S&P 500 companies earnings calendar
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar
Healthcare sector

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$97.34
BSX price is $97.34

Price All-time High

$106.17
BSX price is currently -8.32% below its historical high of $106.17

Price Analysts Target

$118.00
BSX price is currently -17.51% lower than the consensus analysts' forecast

Price Most Recent Change

-3.26%
BSX price was down -3.26% on Mar 8, 2025

Price YTD Change

+7.9%
BSX price is up +7.9% since January 1st

Price 3-Year Change

+128.77%
BSX price is up +128.77% over the past 3 years

Market cap

Market Cap

$143.65 B
BSX market capitalization is $143.65 billion

Market Cap 3-Year Change

+136.63%
BSX market capitalization is up +136.63% over the past 3 years

Market Cap All-time High

$156.68 B
BSX market capitalization is currently -8.32% below its historical high of $156.68 billion

Market Cap Sector Rank

98.6%
BSX market capitalization is higher than 98.6% of companies in Healthcare sector

Technical

Beta

0.61
BSX beta is 0.61

200-day SMA

$86.34
BSX price is currently +12.74% above its 200-day simple moving average

14-day RSI

39.71
BSX 14-day relative strength index is 39.71

30-day Relative Volume

1.49
BSX 30-day relative volume is 1.49

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$16.75 B
BSX annual revenue is $16.75 billion

Annual Revenue Analysts Estimate

$19.15 B
BSX annual revenue is currently -12.53% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+17.61%
BSX annual revenue is up +17.61% year-on-year

Annual Revenue Sector Rank

96.1%
BSX annual revenue is higher than 96.1% of companies in Healthcare sector

Profit

Annual Gross Profit

$11.46 B
BSX annual gross profit is $11.46 billion

Annual Gross Margin

68.41%
BSX annual gross profit margin is 68.41%

Annual Operating Profit

$3.00 B
BSX annual operating income is $3.00 billion

Annual Operating Margin

17.93%
BSX annual operating profit margin is 17.93%

Annual Net Income

$1.85 B
BSX annual net profit is $1.85 billion

Annual Net Margin

11.07%
BSX annual net profit margin is 11.07%

EPS

Annual EPS

$1.25
BSX annual earnings per share is $1.25

Annual EPS Analysts Estimate

$2.86
BSX annual earnings per share is currently -56.24% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+16.82%
BSX annual earnings per share is up +16.82% year-on-year

Annual EPS Sector Rank

89.54%
BSX annual earnings per share is higher than 89.54% of companies in Healthcare sector

ROA & ROE

Annual ROA

4.98%
BSX annual return on assets is 4.98%

Annual ROE

8.93%
BSX annual return on equity is 8.93%

EBIT & EBITDA

Annual EBIT

$2.59 B
BSX annual earnings before interest & taxes is $2.59 billion

Annual EBITDA

$3.44 B
BSX annual EBITDA is $3.44 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

77.87
BSX price to earnings ratio is 77.87

PE Ratio Sector Rank

86.21%
BSX price to earnings ratio is higher than 86.21% of companies in Healthcare sector

PB Ratio

PB Ratio

6.60
BSX price to book ratio is 6.60

PB Ratio Sector Rank

86.99%
BSX price to book ratio is higher than 86.99% of companies in Healthcare sector

PS Ratio

PS Ratio

8.58
BSX price to sales ratio is 8.58

PS Ratio Sector Rank

75.49%
BSX price to sales ratio is higher than 75.49% of companies in Healthcare sector

Enterprise value

Enterprise Value

$154.39 B
BSX enterprise value is $154.39 billion

Enterprise Value Sector Rank

98.51%
BSX enterprise value is higher than 98.51% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

41.36
BSX EV/EBITDA is 41.36

EV/EBITDA Sector Rank

95.8%
BSX EV/EBITDA is higher than 95.8% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.08
BSX annual current ratio is 1.08

Annual Quick Ratio

0.64
BSX annual quick ratio is 0.64

Leverage

Annual Debt To Equity

0.49
BSX annual debt to equity ratio is 0.49

Annual Interest Coverage Ratio

8.48
BSX annual interest coverage ratio is 8.48

Risk & Stability

Piotroski F-Score

5
BSX piotroski f-score is 5

Altman Z-Score

5.71
BSX altman z-score is 5.71

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$39.40 B
BSX annual total assets is $39.40 billion

Annual Non Current Assets

$32.48 B
BSX annual long term assets is $32.48 billion

Annual Current Assets

$6.92 B
BSX annual total current assets is $6.92 billion

Annual Cash & Cash Equivalents

$414.00 M
BSX annual cash & cash equivalents is $414.00 million

Equity

Annual Book Value

$21.77 B
BSX annual book value is $21.77 billion

Annual Working Capital

$521.00 M
BSX annual working capital is $521.00 million

Liabilities

Annual Total Liabilities

$17.39 B
BSX annual total liabilities is $17.39 billion

Annual Total Long Term Liabilities

$10.99 B
BSX annual total long term liabilities is $10.99 billion

Annual Current Liabilities

$6.40 B
BSX annual total current liabilities is $6.40 billion

Annual Accounts Payable

$960.00 M
BSX annual accounts payable is $960.00 million

Debt

Annual Total Debt

$11.15 B
BSX annual total debt is $11.15 billion

Annual Total Debt 1-Year Change

+17.44%
BSX annual total debt is up +17.44% year-on-year

Annual Long Term Debt

$9.37 B
BSX annual long term debt is $9.37 billion

Annual Short Term Debt

$1.78 B
BSX annual short term debt is $1.78 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$13.74 B
BSX annual total expenses is $13.74 billion

Annual Operating Expenses

$8.46 B
BSX annual total operating expenses is $8.46 billion

Annual Cost Of Goods Sold

$5.29 B
BSX annual cost of goods sold is $5.29 billion

Annual SGA

$5.98 B
BSX annual SGA is $5.98 billion

Annual D&A

$1.27 B
BSX annual depreciation & amortization is $1.27 billion

Annual Interest Expense

$305.00 M
BSX annual interest expense is $305.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$3.44 B
BSX annual cash flow from operations is $3.44 billion

Annual CFO 1-Year Change

+37.24%
BSX annual cash flow from operations is up +37.24% year-on-year

Annual CFI

-$5.69 B
BSX annual cash flow from investing activities is -$5.69 billion

Annual CFI 1-Year Change

-120.94%
BSX annual cash flow from investing activities is down -120.94% year-on-year

Annual CFF

$1.81 B
BSX annual cash flow from financing activities is $1.81 billion

Annual CFF 1-Year Change

+36180%
BSX annual cash flow from financing activities is up +36180% year-on-year

Free CashFlow

Annual FCF

$2.37 B
BSX annual free cash flow is $2.37 billion

Annual FCF 1-Year Change

+38.87%
BSX annual free cash flow is up +38.87% year-on-year

CAPEX

Annual CAPEX

$1.07 B
BSX annual capital expenditures is $1.07 billion

Annual CAPEX 1-Year Change

+33.75%
BSX annual capital expenditures is up +33.75% year-on-year

Institutional Ownership

Similar stocks

SYK logo
Stryker (SYK)
GILD logo
Gilead Sciences (GILD)
SNY logo
Sanofi (SNY)
PFE logo
Pfizer (PFE)
DHR logo
Danaher (DHR)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
BMY logo
Bristol-Myers Squibb (BMY)
MDT logo
Medtronic (MDT)
AMGN logo
Amgen (AMGN)

FAQ

  • What is the ticker symbol for Boston Scientific?
  • Does Boston Scientific pay dividends?
  • What sector is Boston Scientific in?
  • What industry is Boston Scientific in?
  • What country is Boston Scientific based in?
  • When did Boston Scientific go public?
  • Is Boston Scientific in the S&P 500?
  • Is Boston Scientific in the NASDAQ 100?
  • Is Boston Scientific in the Dow Jones?
  • When was Boston Scientific's last earnings report?
  • When does Boston Scientific report earnings?
  • Should I buy Boston Scientific stock now?

What is the ticker symbol for Boston Scientific?

The ticker symbol for Boston Scientific is NYSE:BSX

Does Boston Scientific pay dividends?

No, Boston Scientific does not pay dividends

What sector is Boston Scientific in?

Boston Scientific is in the Healthcare sector

What industry is Boston Scientific in?

Boston Scientific is in the Medical Devices industry

What country is Boston Scientific based in?

Boston Scientific is headquartered in United States

When did Boston Scientific go public?

Boston Scientific's initial public offering (IPO) was on May 19, 1992

Is Boston Scientific in the S&P 500?

Yes, Boston Scientific is included in the S&P 500 index

Is Boston Scientific in the NASDAQ 100?

No, Boston Scientific is not included in the NASDAQ 100 index

Is Boston Scientific in the Dow Jones?

No, Boston Scientific is not included in the Dow Jones index

When was Boston Scientific's last earnings report?

Boston Scientific's most recent earnings report was on Feb 5, 2025

When does Boston Scientific report earnings?

The next expected earnings date for Boston Scientific is Apr 24, 2025

Should I buy Boston Scientific stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions